Decennial follow-up in patients with recurrent tachycardia originating from the right ventricular outflow tract: electrophysiologic characteristics and response to treatment

Aims In the setting of right ventricular outflow tract-tachycardia (RVOT-T), data about long-term follow-up (FU) with respect to the therapeutic strategies are missing. All patients (pts) referred to our institution during the last 20 years for the treatment of RVOT-T were studied in a retrospective...

Full description

Saved in:
Bibliographic Details
Published in:European heart journal 2007-10, Vol.28 (19), p.2338-2345
Main Authors: Ventura, Rodolfo, Steven, Daniel, Klemm, Hanno U., Lutomsky, Boris, Müllerleile, Kai, Rostock, Thomas, Servatius, Helge, Risius, Tim, Meinertz, Thomas, Kuck, Karl-Heinz, Willems, Stephan
Format: Article
Language:English
Subjects:
Adult
Anti-Arrhythmia Agents - therapeutic use
Biological and medical sciences
Cardiac dysrhythmias
Cardiac Electrophysiology
Cardiology. Vascular system
Catheter Ablation
Coronary Angiography
Drugs
Echocardiography
Exercise Test
Female
Follow-Up Studies
Heart
Humans
Idiopathic ventricular tachycardia
Male
Medical sciences
Middle Aged
Prognosis
Recurrence
Retrospective Studies
Tachycardia, Ventricular - mortality
Tachycardia, Ventricular - physiopathology
Tachycardia, Ventricular - therapy
Time Factors
Treatment Outcome
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Aims In the setting of right ventricular outflow tract-tachycardia (RVOT-T), data about long-term follow-up (FU) with respect to the therapeutic strategies are missing. All patients (pts) referred to our institution during the last 20 years for the treatment of RVOT-T were studied in a retrospective analysis to assess mortality and efficacy of treatment. Methods and results One hundred and thirty-three patients (77 female; 39 ± 13 years) with sustained RVOT-T were included in this study. At the time of first presentation, diagnosis of RVOT-T was made by complete invasive and non-invasive diagnostic assessment, including electrophysiology study and two-dimensional echocardiography. After 135 ± 68 months (median 136, range 29–248), patients were invited to undergo clinical assessment. Of the 133 pts, 127 (95%) survived and six (5%) died from non-cardiac disease. Anti-arrhythmic (AA) drugs were given to 62 of the 133 pts (47%); of them 32 (52%) had recurrences during follow-up. The mean time to recurrence was 10.02 years (95% CI 7.46–12.59). The other 71 study patients (53%) underwent catheter ablation. The procedure was successful in 58 pts (82%). During follow-up, 30 (52%) of the 58 successfully treated patients had recurrences of RVOT-T. The mean time to recurrence was 6.28 years (95% CI 4.96–7.6). RVOT-T recurrences were similar in morphology to those treated previously in 33% and different in 67% of cases. Conclusions Long-term follow-up in patients with RVOT-T is favourable. Catheter ablation is effective in this setting. However, late recurrences with similar or different morphology may arise in half of the patients after initially successful treatment. AA drug therapy is a valid initial therapeutic option, since it is effective in about half of the patients.
ISSN:0195-668X
1522-9645
DOI:10.1093/eurheartj/ehm293